Goldschmidt, Hartmut
,
Mai, Elias K. http://orcid.org/0000-0002-6226-1252
Dürig, Jan
Scheid, Christof
Weisel, Katja C.
Kunz, Christina
Bertsch, Uta
Hielscher, Thomas
Merz, Maximilian
Munder, Markus
Lindemann, Hans-Walter
Hügle-Dörr, Barbara
Tichy, Diana
Giesen, Nicola
Hose, Dirk
Seckinger, Anja
Huhn, Stefanie
Luntz, Steffen
Jauch, Anna
Elmaagacli, Ahmet
Rabold, Bernhard
Fuhrmann, Stephan
Brossart, Peter
Goerner, Martin
Bernhard, Helga
Hoffmann, Martin
Hillengass, Jens
Raab, Marc S.
Blau, Igor W.
Hänel, Mathias
Salwender, Hans J.
Funding for this research was provided by:
Celgene (N/A)
F. Hoffmann-La Roche Ltd | Chugai Pharmaceutical (N/A)
Article History
Received: 3 September 2019
Revised: 27 December 2019
Accepted: 22 January 2020
First Online: 7 February 2020
Compliance with ethical standards
:
: HG: honoraria: Amgen, BMS, Celgene, Chugai, Janssen, Novartis, Takeda; consulting or advisory role: Amgen, BMS, Celgene, Chugai, Janssen, Novartis, Takeda; speakers bureau: Amgen, BMS, Celgene, Janssen, Novartis, Takeda; research funding: Amgen, BMS, Celgene, Chugai, Janssen, Novartis, Takeda; travel, accomodations, expenses: BMS, Celgene, Janssen, Novartis, Takeda. EKM: honoraria: Janssen, Celgene, Takeda; consulting or advisory role: Janssen, Celgene, Takeda; research funding: Takeda; travel, accomodations, expenses: Janssen, Takeda, Celgene, Onyx, Mundipharma. JD: consulting or advisory role: Celgene; speakers bureau: Celgene; travel, accomodations, expenses: Celgene. CS: honoraria: BMS, Janssen, Celgene, Novartis, Amgen, Takeda; consulting or advisory role: BMS, Janssen, Celgene, Novartis, Amgen, Takeda; speakers bureau: Takeda; research funding: Takeda, Novartis; travel, accomodations, expenses: BMS, Janssen, Celgene, Novartis, Amgen, Takeda. KCW: honoraria: AMGEN, BMS, Celgene, Novartis, Janssen, Takeda; consulting or advisory role: AMGEN, BMS, Celgene, Juno, Janssen, Adaptive, Sanofi, Takeda; research funding: AMGEN, Celgene, Sanofi, Janssen; CK: no COI. UB: travel, accomodations, expenses: Sanofi TH: no COI. MMe: consulting or advisory role: Amgen, Takeda; research funding: Takeda; travel, accomodations, expenses: Celgen, AMGEN, Takeda, Abbvie, Janssen. MMu: honoraria: Janssen, BMS, Takeda, Celgene, Amgen; consulting or advisory role: Janssen, BMS, Takeda, Celgene, Amgen; research funding: BMS; travel, accomodations, expenses: Janssen, BMS, Takeda, Amgen. HWL: no COI. BHD: no COI. DT: no COI. NG: consulting or advisory role: Pfizer; travel, accomodations, expenses: Celgene, BMS. DH: consulting or advisory role: I. Lamkap Bio AG. Discoveric AG; research funding: Celgene AG. Sanofi. Engmab AG; travel, accomodations, expenses: Celgene. AS: consulting or advisory role: I. Lamkap Bio AG. Discoveric AG; research funding: Celgene AG. Sanofi. Engmab AG. SH: honoraria: Janssen; travel, accomodations, expenses: Celgene. SL: no COI. AJ: no COI. AE: consulting or advisory role: Amgen; travel, accomodations, expenses: Janssen, Amgen. BR: no COI. SF: consulting or advisory role: Sanofi, BMS, Amgen. PB: consulting or advisory role: BMS, AMGEN,Roche, MSD; research funding: BMS; travel, accomodations, expenses: BMS. MG: no COI. HB: no COI. MH: honoraria: MSD. JH: honoraria: AMGEN, Janssen; research funding: Celgene; travel, accomodations, expenses: AMGEN, Janssen. MSR: honoraria: Celgene, BMS, Novartis, Janssen, Takeda; consulting or advisory role: Celgene, BMS, Novartis, Janssen, Takeda; research funding: Celgene, Novartis, AMGEN; travel, accomodations, expenses: Janssen, BMS, Takeda. IWB: research funding: Celgene, BMS, Janssen. MH: honoraria: Novartis, Amgen, Roche, Takeda; consulting or advisory role: Celgene. HJS: honoraria: Celgene, Janssen, Cilag; travel, accomodations, expenses: Celgene, Janssen, Cilag.